New platform coming soon — AI-Based Analysis with Human-Generated Insights

Market News & Insights

American Analyst Updates: Oct 27th, 2026

American Analyst Updates: Oct 27th, 2026

Analyst Ratings (USA)

Wall Street analysts demonstrated a selective approach to equity valuations, favouring companies with identifiable earnings-growth catalysts while reducing expectations for businesses facing operational or economic uncertainty. Semiconductor infrastructure, AI-related software and select biotechnology companies attracted positive revisions, with Broadcom, Cadence Design Systems, Palantir and Xencor among notable beneficiaries. Healthcare and energy forecasts were mixed, while telecommunications and several consumer-sensitive companies experienced downward target adjustments. Overall, the day’s activity suggests analysts continue to favour stock-specific opportunities, with greater emphasis on earnings quality, valuation discipline and sustainable profitability.

Updates (343)

Abbott Laboratories (ABT) — Argus downgraded its rating from Buy to Hold.

Agilysys (AGYS) — Needham maintained its Buy rating and raised its price target to $145.00 from $135.00.

Agilysys (AGYS) — Oppenheimer maintained its Outperform rating and raised its price target to $135.00 from $118.00.

Agilysys (AGYS) — Piper Sandler maintained its Overweight rating and raised its price target to $140.00 from $120.00.

Agilysys (AGYS) — UBS established a price target of $145.00 without specifying a rating.

Agree Realty (ADC) — KeyCorp maintained its Overweight rating and lowered its price target to $76.00 from $82.00.

Airbnb (ABNB) — Oppenheimer maintained its Outperform rating and raised its price target to $210.00 from $190.00.

Almonty Industries (ALM) — B. Riley maintained its Buy rating and lowered its price target to $20.00 from $25.00.

Alphabet (GOOG) — Needham reiterated its Buy rating.

American Express (AXP) — Citigroup maintained its Neutral rating and lowered its price target to $335.00 from $340.00.

American Express (AXP) — Evercore established a price target of $330.00 without specifying a rating.

Ameris Bancorp (ABCB) — DA Davidson maintained its Buy rating and lowered its price target to $96.00 from $100.00.

Amkor Technology (AMKR) — B. Riley maintained its Neutral rating and lowered its price target to $41.00 from $46.00.

Amkor Technology (AMKR) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $63.00 from $70.00.

Amkor Technology (AMKR) — Needham maintained its Buy rating and lowered its price target to $55.00 from $90.00.

Amkor Technology (AMKR) — Goldman Sachs established a price target of $56.00 without specifying a rating.

Apollo Global Management (APO) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $124.00 from $134.00.

Apple (AAPL) — Evercore reiterated its Outperform rating.

Apple (AAPL) — HSBC reiterated its Buy rating.

Applied Optoelectronics (AAOI) — Needham maintained its Buy rating and lowered its price target to $170.00 from $190.00.

Ardmore Shipping (ASC) — Evercore reiterated its Outperform rating with a price target of $22.00.

Ares Management (ARES) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $130.00 from $134.00.

argenx (ARGX) — Citigroup maintained its Buy rating and lowered its price target to $1,232.00 from $1,301.00.

ArriVent BioPharma (AVBP) — Guggenheim maintained its Buy rating and raised its price target to $30.00 from $18.00.

Artiva Biotherapeutics (ARTV) — Needham downgraded its rating from Buy to Hold.

Artiva Biotherapeutics (ARTV) — TD Cowen downgraded its rating from Buy to Hold.

Artiva Biotherapeutics (ARTV) — Wedbush downgraded its rating from Outperform to Neutral with a price target of $4.00.

Asbury Automotive Group (ABG) — Craig-Hallum upgraded its rating from Hold to Buy with a price target of $250.00.

Axon Enterprise (AXON) — Needham reiterated its Buy rating.

Badger Meter (BMI) — Argus upgraded its rating from Hold to Buy with a price target of $170.00.

Badger Meter (BMI) — Northcoast Research downgraded its rating from Buy to Neutral.

Banco Bradesco (BBD) — Citigroup’s reiteration entry recorded a change from Buy to Neutral.

Banco Bradesco (BBDO) — Citigroup downgraded its rating to Neutral.

Bank of Hawaii (BOH) — DA Davidson maintained its Neutral rating with a price target of $75.00.

Bank of Hawaii (BOH) — Keefe, Bruyette & Woods downgraded its rating from Outperform to Market Perform and lowered its price target to $78.00 from $85.00.

Bank of Marin Bancorp (BMRC) — DA Davidson maintained its Buy rating with a price target of $34.00.

Baytex Energy (BTE) — Jefferies initiated coverage with a Buy rating.

Beacon Financial (BBT) — Piper Sandler maintained its Overweight rating and raised its price target to $35.00 from $33.00.

Beam Therapeutics (BEAM) — H.C. Wainwright reiterated its Buy rating.

BellRing Brands (BRBR) — JPMorgan maintained its Overweight rating and lowered its price target to $15.00 from $18.00.

Bentley Systems (BSY) — Rosenblatt reiterated its Buy rating with a price target of $50.00.

Best Buy (BBY) — Evercore established a price target of $100.00 without specifying a rating.

Blue Owl Capital (OWL) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $11.00 from $12.00.

Boeing (BA) — Jefferies reiterated its Buy rating.

Boston Beer Company (SAM) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $200.00 from $190.00.

BR Biopharma (BRBI) — Citigroup’s reiteration entry recorded a change from Buy to Neutral.

Brixmor Property Group (BRX) — Stifel maintained its Hold rating and lowered its price target to $30.50 from $32.00.

Broadcom (AVGO) — Citigroup downgraded its rating from Buy to Neutral.

Broadcom (AVGO) — DA Davidson upgraded its rating from Neutral to Buy and raised its price target to $400.00 from $350.00.

Broadcom (AVGO) — H.C. Wainwright initiated coverage with a Buy rating.

Broadcom (AVGO) — Oppenheimer’s initiation entry listed a change from Outperform to Buy.

Broadcom (AVGO) — Rosenblatt reiterated its Buy rating with a price target of $600.00.

Broadcom (AVGO) — UBS downgraded its rating from Hold to Neutral.

Broadcom (AVGO) — Wedbush initiated coverage with an Outperform rating.

Broadcom (AVGO) — William Blair downgraded its rating from Outperform to Market Perform.

Burlington Stores (BURL) — Bank of America maintained its Buy rating and lowered its price target to $344.00 from $365.00.

Business First Bancshares (BFST) — DA Davidson maintained its Buy rating and raised its price target to $39.00 from $35.00.

C&F Financial (CFFI) — DA Davidson reiterated its Buy rating with a price target of $115.00.

CACI International (CACI) — JPMorgan maintained its Overweight rating and raised its price target to $725.00 from $715.00.

Cadence Design Systems (CDNS) — JPMorgan maintained its Overweight rating and raised its price target to $420.00 from $405.00.

Cadence Design Systems (CDNS) — KeyCorp reiterated its Overweight rating.

Cadence Design Systems (CDNS) — Mizuho established a price target of $400.00 without specifying a rating.

Cadence Design Systems (CDNS) — Needham maintained its Buy rating and raised its price target to $430.00 from $400.00.

Cadence Design Systems (CDNS) — Baird maintained its Outperform rating and raised its price target to $440.00 from $420.00.

CAE (CAE) — Scotiabank reiterated its Outperform rating.

Cal-Maine Foods (CALM) — BMO Capital Markets reiterated its Market Perform rating.

Capital One Financial (COF) — Evercore reiterated its Outperform rating with a price target of $230.00.

CareDx (CDNA) — BTIG maintained its Buy rating and raised its price target to $81.00 from $74.00.

Caris Life Sciences (CAI) — BTIG maintained its Buy rating and raised its price target to $38.00 from $33.00.

Carlyle Group (CG) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $46.00 from $56.00.

CB Financial Services (CBFV) — DA Davidson reiterated its Buy rating with a price target of $44.00.

Celestica (CLS) — TD Cowen reiterated its Buy rating.

Cemex (CX) — RBC maintained its Sector Perform rating and raised its price target to $13.75 from $13.25.

Cemex (CX) — Scotiabank maintained its Sector Outperform rating and lowered its price target to $13.80 from $14.50.

Centrus Energy (LEU) — Capital One established a price target of $151.00 without specifying a rating.

Centuri Holdings (CTRI) — Wells Fargo maintained its Overweight rating and lowered its price target to $28.00 from $29.00.

CF Industries (CF) — UBS reiterated its Neutral rating.

Chemung Financial (CHMG) — Raymond James reiterated its Outperform rating with a price target of $90.00.

Chemung Financial (CHMG) — UBS reiterated its Outperform rating.

Chubb (CB) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $360.00 from $350.00.

Churchill Downs (CHDN) — Stifel maintained its Buy rating and lowered its price target to $132.00 from $139.00.

Citizens Financial Group (CFG) — Evercore established a price target of $74.00 without specifying a rating.

City Holding (CHCO) — Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $147.00 from $145.00.

Clearwater Paper (CLW) — RBC maintained its Outperform rating and lowered its price target to $22.00 from $23.00.

Clearwater Paper (CLW) — Truist maintained its Hold rating and lowered its price target to $17.00 from $20.00.

Climb Bio (CLYM) — BTIG reiterated its Buy rating with a price target of $32.00.

Climb Bio (CLYM) — Piper Sandler reiterated its Overweight rating.

CNB Financial (CCNE) — Raymond James reiterated its Outperform rating with a price target of $40.00.

Cognizant Technology Solutions (CTSH) — Guggenheim maintained its Buy rating and raised its price target to $80.00 from $65.00.

Cognizant Technology Solutions (CTSH) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $70.00 from $51.00.

Columbia Banking System (COLB) — TD Cowen maintained its Hold rating and raised its price target to $33.00 from $32.00.

Community West Bancshares (CWBC) — DA Davidson maintained its Buy rating and raised its price target to $31.00 from $29.00.

ConocoPhillips (COP) — Piper Sandler resumed coverage with a Neutral rating and a price target of $157.00.

Constellation Brands (STZ) — RBC reiterated its Outperform rating.

Criteo (CRTO) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $15.00 from $16.00.

CSX Corporation (CSX) — Susquehanna maintained its Positive rating and raised its price target to $60.00 from $55.00.

Custom Truck One Source (CTOS) — Cantor Fitzgerald reiterated its Overweight rating with a price target of $14.00.

Custom Truck One Source (CTOS) — DA Davidson reiterated its Buy rating with a price target of $13.00.

DarioHealth (DRIO) — BTIG initiated coverage with a Buy rating and a price target of $6.00.

Datadog (DDOG) — UBS reiterated its Buy rating with a price target of $320.00.

Delek US Holdings (DK) — Piper Sandler resumed coverage with a Neutral rating and a price target of $90.00.

DHT Holdings (DHT) — Evercore established a price target of $26.00 without specifying a rating.

Dianthus Therapeutics (DNTH) — Roth Capital initiated coverage with a Buy rating and a price target of $113.00.

Dick’s Sporting Goods (DKS) — BNP Paribas Exane reiterated its Underperform rating.

DigitalOcean (DOCN) — Citigroup reiterated its Buy rating.

DoorDash (DASH) — TD Cowen reiterated its Buy rating.

Dycom Industries (DY) — Oppenheimer initiated coverage with a Market Perform rating.

Dynatrace (DT) — Citigroup maintained its Buy rating and raised its price target to $75.00 from $65.00.

eBay (EBAY) — UBS reiterated its Neutral rating with a price target of $131.00.

Edwards Lifesciences (EW) — Deutsche Bank established a price target of $104.00 without specifying a rating.

Edwards Lifesciences (EW) — TD Cowen reiterated its Buy rating.

Elevance Health (ELV) — Wells Fargo maintained its Overweight rating and raised its price target to $492.00 from $473.00.

Energous (WATT) — H.C. Wainwright initiated coverage with a Buy rating and a price target of $15.00.

Envoy Medical (COCH) — Lake Street Capital maintained its Buy rating and raised its price target to $25.00 from $2.50.

EQT Corporation (EQT) — Scotiabank maintained its Sector Perform rating and lowered its price target to $53.00 from $54.00.

EQT Corporation (EQT) — Stephens maintained its Overweight rating and raised its price target to $75.00 from $71.00.

EQT Corporation (EQT) — UBS established a price target of $75.00 without specifying a rating.

EQT Corporation (EQT) — Wells Fargo maintained its Overweight rating and lowered its price target to $71.00 from $79.00.

Ermenegildo Zegna (ZGN) — RBC initiated coverage with an Outperform rating and a price target of $16.00.

eToro Group (ETOR) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $48.00 from $53.00.

Evergy (EVRG) — Truist initiated coverage with a Buy rating and a price target of $97.00.

Fabrinet (FN) — Needham maintained its Buy rating and lowered its price target to $500.00 from $650.00.

Fair Isaac (FICO) — Citigroup reiterated its Neutral rating.

Fate Therapeutics (FATE) — Wedbush reiterated its Outperform rating with a price target of $7.00.

FedEx (FDX) — Bank of America maintained its Buy rating and lowered its price target to $359.00 from $378.00.

Ferguson Enterprises (FERG) — Citigroup upgraded its rating from Neutral to Buy and raised its price target to $288.00 from $285.00.

Fifth Third Bancorp (FITB) — Wolfe Research resumed coverage with an Outperform rating.

First BanCorp (FBP) — Raymond James reiterated its Strong Buy rating.

First Solar (FSLR) — Guggenheim maintained its Buy rating and raised its price target to $299.00 from $282.00.

Fiserv (FISV) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $48.00 from $50.00.

Flagstar Bank (FLG) — Cantor Fitzgerald reiterated its Overweight rating with a price target of $16.00.

Flagstar Bank (FLG) — Citigroup maintained its Buy rating and lowered its price target to $14.00 from $18.00.

Flex (FLEX) — Bank of America maintained its Buy rating and lowered its price target to $150.00 from $180.00.

Flutter Entertainment (FLUT) — UBS reiterated its Buy rating with a price target of $130.00.

Frontline (FRO) — Evercore established a price target of $53.00 without specifying a rating.

Fulton Financial (FULT) — Stephens maintained its Overweight rating and lowered its price target to $25.00 from $26.00.

Galaxy Digital (GLXY) — BTIG maintained its Buy rating and lowered its price target to $35.00 from $45.00.

Galaxy Digital (GLXY) — Chardan Capital reiterated its Buy rating with a price target of $35.00.

Genmab (GMAB) — JPMorgan upgraded its rating from Neutral to Overweight.

Greenbrier Companies (GBX) — Bank of America maintained its Underperform rating and lowered its price target to $38.00 from $42.00.

Guardant Health (GH) — BTIG maintained its Buy rating and raised its price target to $210.00 from $195.00.

Hamilton Lane (HLNE) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $95.00 from $116.00.

Hawkins (HWKN) — BWS Financial reiterated its Buy rating with a price target of $200.00.

HBT Financial (HBT) — DA Davidson established a price target of $39.00 without specifying a rating.

HBT Financial (HBT) — Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to $43.00 from $41.00.

HBT Financial (HBT) — Piper Sandler maintained its Neutral rating and raised its price target to $40.00 from $39.00.

HealthStream (HSTM) — Citigroup reiterated its Market Perform rating.

Heartland Express (HTLD) — Barclays maintained its Underweight rating and lowered its price target to $10.00 from $12.00.

Hershey (HSY) — RBC reiterated its Sector Perform rating.

HF Sinclair (DINO) — Piper Sandler resumed coverage with an Overweight rating and a price target of $152.00.

Howmet Aerospace (HWM) — Citigroup reiterated its Buy rating.

HubSpot (HUBS) — Citigroup maintained its Neutral rating and raised its price target to $287.00 from $210.00.

HubSpot (HUBS) — UBS downgraded its rating from Buy to Neutral and raised its price target to $310.00 from $290.00.

Huntington Bancshares (HBAN) — Wolfe Research resumed coverage with a Peer Perform rating.

Hyperfine (HYPR) — Loop Capital established a price target of $2.00 without specifying a rating.

IDEXX Laboratories (IDXX) — UBS established a price target of $627.00 without specifying a rating.

Immunome (IMNM) — H.C. Wainwright reiterated its Buy rating.

Immunome (IMNM) — Wedbush reiterated its Outperform rating with a price target of $35.00.

Incyte (INCY) — BMO Capital Markets reiterated its Market Perform rating.

Incyte (INCY) — H.C. Wainwright reiterated its Buy rating.

Incyte (INCY) — Oppenheimer established a price target of $152.00 without specifying a rating.

INNIO (INIO) — BNP Paribas Exane maintained its Outperform rating and lowered its price target to $35.00 from $43.00.

Innovex International (INVX) — JPMorgan initiated coverage with a Neutral rating and a price target of $33.00.

Insmed (INSM) — H.C. Wainwright reiterated its Buy rating.

Integra LifeSciences (IART) — UBS established a price target of $14.00 without specifying a rating.

Intel (INTC) — Needham reiterated its Hold rating.

Intel (INTC) — Rosenblatt reiterated its Sell rating with a price target of $80.00.

Intel (INTC) — Wedbush reiterated its Neutral rating with a price target of $98.00.

Investar Holding (ISTR) — Piper Sandler maintained its Neutral rating and lowered its price target to $31.00 from $32.50.

Jade Biosciences (JBIO) — BTIG reiterated its Buy rating with a price target of $77.00.

JFrog (FROG) — KeyCorp reiterated its Overweight rating.

Kaiser Aluminum (KALU) — UBS reiterated its Buy rating with a price target of $158.00.

Kforce (KFRC) — Baird maintained its Outperform rating and raised its price target to $66.00 from $63.00.

Kforce (KFRC) — UBS reiterated its Neutral rating.

Kforce (KFRC) — UBS also established a price target of $63.00.

Kinder Morgan (KMI) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $40.00 from $38.00.

Kinder Morgan (KMI) — Scotiabank maintained its Sector Perform rating and raised its price target to $34.00 from $32.00.

Kinder Morgan (KMI) — UBS reiterated its Buy rating.

KKR (KKR) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $109.00 from $118.00.

Knife River (KNF) — Wolfe Research upgraded its rating from Peer Perform to Outperform.

Kodiak Gas Services (KGS) — Bank of America maintained its Buy rating and lowered its price target to $74.00 from $83.00.

Kymera Therapeutics (KYMR) — Morgan Stanley maintained its Overweight rating and raised its price target to $146.00 from $135.00.

Lakeland Financial (LKFN) — Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $64.00 from $63.00.

LCI Industries (LCII) — Roth Capital established a price target of $112.00 without specifying a rating.

Life Time Group Holdings (LTH) — Mizuho maintained its Outperform rating and raised its price target to $68.00 from $64.00.

Life Time Group Holdings (LTH) — Morgan Stanley maintained its Overweight rating and raised its price target to $54.00 from $53.00.

Liftoff Mobile (LFTO) — Wedbush initiated coverage with an Outperform rating and a price target of $25.00.

M&T Bank (MTB) — Wolfe Research resumed coverage with an Underperform rating and a price target of $198.00.

MACOM Technology Solutions (MTSI) — Raymond James upgraded its rating from Market Perform to Outperform with a price target of $300.00.

MakeMyTrip (MMYT) — Bank of America maintained its Buy rating and lowered its price target to $55.00 from $60.00.

Mama’s Creations (MAMA) — Stephens initiated coverage with an Overweight rating and a price target of $19.00.

MasterBrand (MBC) — DA Davidson reiterated its Neutral rating with a price target of $10.00.

Match Group (MTCH) — TD Cowen maintained its Buy rating and raised its price target to $52.00 from $45.00.

MBX Biosciences (MBX) — Citigroup reiterated its Market Outperform rating.

MercadoLibre (MELI) — BTIG reiterated its Buy rating with a price target of $2,150.00.

MercadoLibre (MELI) — Citigroup upgraded its rating from Neutral to Buy and lowered its price target to $2,050.00 from $2,100.00.

Mercer International (MERC) — CIBC downgraded its rating from Neutral to Sector Underperform.

Metropolitan Bank Holding (MCB) — UBS reiterated its Neutral rating.

Miami International Holdings (MIAX) — Rosenblatt maintained its Buy rating and lowered its price target to $60.00 from $62.00.

Microsoft (MSFT) — Raymond James reiterated its Outperform rating with a price target of $630.00.

Microsoft (MSFT) — Wells Fargo reiterated its Overweight rating.

Mid Penn Bancorp (MPB) — Piper Sandler maintained its Overweight rating and lowered its price target to $40.00 from $42.00.

Midland States Bancorp (MSBI) — Stephens maintained its Equal Weight rating and raised its price target to $36.00 from $34.00.

Moderna (MRNA) — William Blair downgraded its rating from Outperform to Market Perform.

Modine Manufacturing (MOD) — DA Davidson reiterated its Buy rating with a price target of $330.00.

Moelis & Company (MC) — JPMorgan maintained its Neutral rating and lowered its price target to $68.00 from $70.00.

Molina Healthcare (MOH) — JPMorgan maintained its Neutral rating and raised its price target to $225.00 from $220.00.

Molina Healthcare (MOH) — Bernstein reiterated its Outperform rating.

monday.com (MNDY) — Needham reiterated its Buy rating with a price target of $125.00.

monday.com (MNDY) — UBS reiterated its Buy rating.

Mosaic (MOS) — UBS established a price target of $19.00 without specifying a rating.

Murphy Oil (MUR) — Goldman Sachs maintained its Neutral rating and raised its price target to $44.00 from $36.00.

Natera (NTRA) — BTIG maintained its Buy rating and raised its price target to $430.00 from $320.00.

NB Bancorp (NBBK) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $24.00 from $25.00.

NB Bancorp (NBBK) — New Street Research established a price target of $24.00 without specifying a rating.

Newmont (NEM) — Scotiabank reiterated its Outperform rating and lowered its price target to $148.00 from $149.00.

Nordic American Tankers (NAT) — Evercore reiterated its Underperform rating with a price target of $7.00.

Northrop Grumman (NOC) — Bernstein maintained its Market Perform rating and raised its price target to $590.00 from $556.00.

Northwest Natural (NWN) — Truist initiated coverage with a Hold rating and a price target of $54.00.

Novavax (NVAX) — Cantor Fitzgerald reiterated its Overweight rating.

NRG Energy (NRG) — Barclays maintained its Overweight rating and lowered its price target to $163.00 from $204.00.

Nutrien (NTR) — UBS reiterated its Sell rating.

Nyxoah (NYXH) — Cantor Fitzgerald reiterated its Overweight rating with a price target of $3.00.

Nyxoah (NYXH) — Raymond James established a price target of $3.00 without specifying a rating.

Occidental Petroleum (OXY) — Goldman Sachs maintained its Buy rating and raised its price target to $76.00 from $69.00.

Occidental Petroleum (OXY) — Piper Sandler resumed coverage with a Neutral rating and a price target of $94.00, according to Briefing.com; the supplied MarketBeat record lists $69.00.

Ollie’s Bargain Outlet (OLLI) — RBC maintained its Outperform rating and raised its price target to $125.00 from $124.00.

OneSpan (OSPN) — Rosenblatt downgraded its rating from Buy to Neutral with a price target of $18.00.

OptimizeRx (OPRX) — Citigroup reiterated its Market Outperform rating.

Oracle (ORCL) — Bernstein reiterated its Outperform rating.

Oric Pharmaceuticals (ORIC) — Wedbush maintained its Outperform rating and lowered its price target to $14.00 from $17.00.

Oruka Therapeutics (ORKA) — H.C. Wainwright reiterated its Buy rating.

Oruka Therapeutics (ORKA) — Wedbush reiterated its Outperform rating with a price target of $165.00.

Ovintiv (OVV) — Goldman Sachs maintained its Buy rating and raised its price target to $72.00 from $65.00.

Ovintiv (OVV) — Stephens maintained its Equal Weight rating and raised its price target to $77.00 from $75.00.

Owens Corning (OC) — Bank of America maintained its Buy rating and lowered its price target to $145.00 from $155.00.

PagSeguro Digital (PAGS) — Citigroup downgraded its rating from Buy to Neutral and lowered its price target to $8.00 from $13.00.

Palantir Technologies (PLTR) — Rosenblatt maintained its Buy rating and raised its price target to $260.00 from $225.00.

Par Pacific Holdings (PARR) — Piper Sandler resumed coverage with a Neutral rating and a price target of $94.00.

Patrick Industries (PATK) — Roth Capital reiterated its Buy rating with a price target of $96.00.

Paycom Software (PAYC) — Citigroup maintained its Neutral rating and raised its price target to $279.00 from $194.00.

Paycom Software (PAYC) — Jefferies maintained its Hold rating and raised its price target to $300.00 from $160.00.

Paylocity (PCTY) — Citigroup maintained its Buy rating and raised its price target to $208.00 from $168.00.

PayPal (PYPL) — BTIG reiterated its Neutral rating.

PayPal (PYPL) — Evercore established a price target of $45.00 without specifying a rating.

PayPal (PYPL) — Needham reiterated its Hold rating.

PBF Energy (PBF) — Piper Sandler’s supplied MarketBeat entry lists a change from Overweight to Neutral with a $94.00 price target; the action requires verification.

Pinnacle Financial Partners (PNFP) — Evercore reiterated its Outperform rating.

Pinnacle Financial Partners (PNFP) — UBS reiterated its Buy rating.

Planet Fitness (PLNT) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $55.00 from $51.00.

PNC Financial Services (PNC) — Wolfe Research resumed coverage with a Peer Perform rating.

PolyPid (PYPD) — Oppenheimer initiated coverage with an Outperform rating and a price target of $10.00.

PPL Corporation (PPL) — Truist initiated coverage with a Buy rating and a price target of $41.00.

Principal Financial Group (PFG) — UBS reiterated its Neutral rating with a price target of $112.00.

Proto Labs (PRLB) — Cantor Fitzgerald reiterated its Overweight rating.

Public Service Enterprise Group (PEG) — Bank of America maintained its Buy rating and lowered its price target to $85.00 from $87.00.

Public Storage (PSA) — UBS reiterated its Neutral rating.

Quanta Services (PWR) — Truist maintained its Buy rating and raised its price target to $960.00 from $945.00.

Rambus (RMBS) — Evercore reiterated its Outperform rating with a price target of $150.00.

Rambus (RMBS) — Rosenblatt reiterated its Buy rating with a price target of $165.00.

Rambus (RMBS) — Susquehanna maintained its Neutral rating and raised its price target to $103.00 from $100.00.

Rambus (RMBS) — UBS established a price target of $165.00 without specifying a rating.

Range Resources (RRC) — Morgan Stanley established a price target of $54.00 without specifying a rating.

Regions Financial (RF) — Evercore reiterated its Underperform rating with a price target of $28.00.

Revolve Group (RVLV) — UBS reiterated its Neutral rating.

Reynolds Consumer Products (REYN) — UBS reiterated its Neutral rating with a price target of $24.00.

Rithm Capital (RITM) — Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to $13.00 from $12.50.

Ross Stores (ROST) — Bank of America maintained its Buy rating and lowered its price target to $258.00 from $265.00.

Ryder System (R) — Susquehanna maintained its Positive rating and raised its price target to $318.00 from $280.00.

Scorpio Tankers (STNG) — Evercore reiterated its Outperform rating with a price target of $97.00.

Selective Insurance Group (SIGI) — Morgan Stanley maintained its Underweight rating and raised its price target to $85.00 from $80.00.

Sensei Biotherapeutics (FTH) — BTIG reiterated its Buy rating with a price target of $55.00.

Senseonics Holdings (SENS) — TD Cowen reiterated its Buy rating with a price target of $15.00.

SharkNinja (SN) — TD Cowen maintained its Buy rating and raised its price target to $230.00 from $205.00.

Sherwin-Williams (SHW) — Jefferies reiterated its Hold rating with a price target of $353.00.

Shopify (SHOP) — Citigroup maintained its Buy rating and raised its price target to $216.00 from $196.00.

Simpson Manufacturing (SSD) — Baird maintained its Outperform rating and raised its price target to $210.00 from $205.00.

Simpson Manufacturing (SSD) — DA Davidson maintained its Neutral rating and lowered its price target to $203.00 from $212.00.

Simpson Manufacturing (SSD) — Stephens maintained its Cautious rating and lowered its price target to $205.00 from $215.00.

Skydance (SKYD) — Huber Research issued an upgrade; the supplied entry did not identify the new rating.

SL Green Realty (SLG) — Truist maintained its Hold rating and lowered its price target to $48.00 from $57.00.

Solid Biosciences (SLDB) — H.C. Wainwright reiterated its Buy rating.

Sphere Entertainment (SPHR) — Morgan Stanley maintained its Overweight rating and lowered its price target to $150.00 from $170.00.

StepStone Group (STEP) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $48.00 from $58.00.

Steven Madden (SHOO) — BTIG reiterated its Buy rating with a price target of $55.00.

Summit Therapeutics (SMMT) — Citigroup reiterated its Market Outperform rating.

Sun Communities (SUI) — UBS reiterated its Neutral rating.

Take-Two Interactive (TTWO) — Bank of America maintained its Buy rating and lowered its price target to $330.00 from $368.00.

Talen Energy (TLN) — Bank of America reiterated its Buy rating.

Talen Energy (TLN) — Barclays maintained its Overweight rating and lowered its price target to $387.00 from $408.00.

Talos Energy (TALO) — Goldman Sachs reiterated its Buy rating with a price target of $22.00.

Tapestry (TPR) — Baird maintained its Outperform rating and lowered its price target to $150.00 from $165.00.

Teekay Tankers (TNK) — Evercore reiterated its Outperform rating with a price target of $116.00.

Texas Capital Bancshares (TCBI) — Citigroup reiterated its Neutral rating.

TJX Companies (TJX) — Bank of America maintained its Buy rating and lowered its price target to $170.00 from $175.00.

TKO Group Holdings (TKO) — Citigroup reiterated its Market Outperform rating.

TKO Group Holdings (TKO) — Goldman Sachs maintained its Buy rating and lowered its price target to $215.00 from $220.00.

Torm (TRMD) — Evercore reiterated its Outperform rating.

TPG (TPG) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $52.00 from $56.00.

Transcat (TRNS) — CJS Securities initiated coverage with a Market Outperform rating and a price target of $115.00.

Travel + Leisure (TNL) — Stifel established a price target of $91.00 without specifying a rating.

Trimble (TRMB) — Loop Capital initiated coverage with a Buy rating and a price target of $76.00.

Triumph Financial (TFIN) — DA Davidson established a price target of $70.00 without specifying a rating.

Truist Financial (TFC) — Evercore reiterated its Outperform rating with a price target of $55.00.

Truist Financial (TFC) — Wolfe Research resumed coverage with a Peer Perform rating.

TuHURA Biosciences (HURA) — H.C. Wainwright reiterated its Buy rating with a price target of $10.00.

Twilio (TWLO) — Wells Fargo raised its price target to $300.00 from $275.00.

Tyler Technologies (TYL) — Needham maintained its Buy rating and raised its price target to $500.00 from $400.00.

U.S. Bancorp (USB) — Wolfe Research resumed coverage with a Peer Perform rating.

UFP Industries (UFPI) — DA Davidson reiterated its Buy rating with a price target of $105.00.

Union Pacific (UNP) — Susquehanna maintained its Positive rating and raised its price target to $345.00 from $333.00.

UnitedHealth Group (UNH) — Morgan Stanley maintained its Overweight rating and raised its price target to $531.00 from $529.00.

UnitedHealth Group (UNH) — Wells Fargo maintained its Overweight rating and lowered its price target to $487.00 from $526.00.

USCB Financial Holdings (USCB) — Piper Sandler maintained its Overweight rating and lowered its price target to $24.00 from $27.00.

UWM Holdings (UWMC) — Compass Point downgraded its rating from Buy to Neutral with a price target of $1.50.

Varonis Systems (VRNS) — Stephens downgraded its rating from Overweight to Equal Weight.

Veritone (VERI) — Needham reiterated its Buy rating.

Verizon Communications (VZ) — Barclays maintained its Equal Weight rating and lowered its price target to $44.00 from $46.00.

Verizon Communications (VZ) — BNP Paribas Exane lowered its price target to $45.00 from $46.00.

Verizon Communications (VZ) — Citigroup lowered its price target to $53.00 from $55.00.

Verizon Communications (VZ) — Daiwa maintained its Buy rating and lowered its price target to $52.00 from $55.00.

Verizon Communications (VZ) — Goldman Sachs lowered its price target to $47.00 from $51.00.

Verizon Communications (VZ) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $50.00 from $52.00.

Verizon Communications (VZ) — TD Cowen maintained its Buy rating and lowered its price target to $55.00 from $56.00.

Vistra (VST) — Bank of America maintained its Buy rating and lowered its price target to $194.00 from $196.00.

Vistra (VST) — Lake Street Capital established a price target of $194.00 without specifying a rating.

Vital Farms (VITL) — DA Davidson established a price target of $10.00 without specifying a rating.

Warby Parker (WRBY) — BTIG reiterated its Buy rating.

Waste Connections (WCN) — UBS reiterated its Buy rating with a price target of $215.00.

Welltower (WELL) — UBS reiterated its Buy rating with a price target of $269.00.

WEX (WEX) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $178.00 from $172.00.

Weyerhaeuser (WY) — CIBC maintained its Outperformer rating and lowered its price target to $25.00 from $30.00.

Weyerhaeuser (WY) — DA Davidson maintained its Buy rating and lowered its price target to $27.00 from $31.00.

Xencor (XNCR) — RBC maintained its Outperform rating and raised its price target to $43.00 from $20.00.

Xencor (XNCR) — Truist maintained its Buy rating and raised its price target to $40.00 from $29.00.

Xencor (XNCR) — Wedbush maintained its Outperform rating and raised its price target to $45.00 from $30.00.

Xencor (XNCR) — Wells Fargo maintained its Overweight rating and raised its price target to $44.00 from $30.00.

Xometry (XMTR) — Cantor Fitzgerald reiterated its Overweight rating.

XP (XP) — Citigroup downgraded its rating from Buy to Neutral and lowered its price target to $15.00 from $25.00.

YETI Holdings (YETI) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $48.00 from $49.00.

Zoetis (ZTS) — UBS reiterated its Neutral rating.

Join the discussion

Your email address will not be published. Required fields are marked *